Application 206541
- Type
- ANDA
- Sponsor
- LUPIN LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | SILODOSIN | SILODOSIN | CAPSULE;ORAL | 4MG | No | No |
| 002 | SILODOSIN | SILODOSIN | CAPSULE;ORAL | 8MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68180-740 | Silodosin | Silodosin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-740 | Silodosin | Silodosin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-740 | Silodosin | Silodosin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-741 | Silodosin | Silodosin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-741 | Silodosin | Silodosin | Lupin Pharmaceuticals, Inc. | ANDA | Current |
| 68180-741 | Silodosin | Silodosin | Lupin Pharmaceuticals, Inc. | ANDA | Current |